ADAP Drug Pricing and ADAP Crisis Task Force
The ADAP Crisis Task Force negotiates with pharmaceutical companies for additional rebates and discounts and has achieved more than $1 billion in savings for ADAPs since its inception in 2003. This paper provides details of ADAP drug pricing and the ADAP Crisis Task Force agreements with companies.